Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies, today announced that the Company's PoNS® ...

Bioness Medical’s PoNS System receives FDA 510(k) clearance to treat dynamic gait deficit due to chronic stroke symptoms: Valencia, California Wednesday, July 1, 2026, 17:00 Hrs ...

Electrical stimulation has proven to be a tremendous aid in many physical rehabilitation cases, as the technologically ...

Gait-related disturbances adversely affect the quality of life of patients with Parkinson's disease (PD), a condition affecting millions worldwide. Although various pharmacological, surgical, and ...

Stroke remains one of the leading causes of long-term disability worldwide, affecting millions each year. Among its most debilitating consequences is gait impairment, which affects over 80% of stroke ...

Functional electrical stimulation (FES) technology is a new type of treatment, which is through the simulation of the nerve on the muscle issued by the electrical signals for rehabilitation training.

Dysphagia, a severe comorbidity of many neurological diseases, often lacks targeted therapies. This critical review assessed ...